Published in Medicine and Law Weekly, April 21st, 2006
"This unfortunate incident makes clear how important it is for consumers to seek out licensed, trained and qualified healthcare professionals when considering treatment with Botox and to verify that they are receiving authentic Botox and not an unlicensed botulinum toxin or alternative substance," said Douglas S. Ingram, Allergan's executive VP, general counsel and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.